285 related articles for article (PubMed ID: 35351217)
1. Effectiveness of two coronavirus disease 2019 (COVID-19) vaccines (viral vector and inactivated viral vaccine) against severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection in a cohort of healthcare workers.
Marra AR; Miraglia JL; Malheiros DT; Guozhang Y; Teich VD; da Silva Victor E; Pinho JRR; Cypriano A; Vieira LW; Polonio M; Ornelas RH; de Oliveira SM; Borges Junior FA; Shibata ARO; Schettino GPP; de Oliveira KG; Ferraz Santana RA; de Mello Malta F; Amgarten D; Boechat AL; Trecenti NMZ; Kobayashi T; Salinas JL; Edmond MB; Rizzo LV
Infect Control Hosp Epidemiol; 2023 Jan; 44(1):75-81. PubMed ID: 35351217
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of Heterologous Coronavirus Disease 2019 (COVID-19) Vaccine Booster Dosing in Brazilian Healthcare Workers, 2021.
Marra AR; Miraglia JL; Malheiros DT; Guozhang Y; Teich VD; da Silva Victor E; Rebello Pinho JR; Cypriano A; Vieira LW; Polonio M; Ornelas RH; de Oliveira SM; Borges Junior FA; Oler SCC; Schettino GPP; de Oliveira KG; Ferraz Santana RA; de Mello Malta F; Amgarten D; Boechat AL; Trecenti NMZ; Kobayashi T; Salinas JL; Edmond MB; Rizzo LV
Clin Infect Dis; 2023 Feb; 76(3):e360-e366. PubMed ID: 35639918
[TBL] [Abstract][Full Text] [Related]
3. Longer-term effectiveness of a heterologous coronavirus disease 2019 (COVID-19) vaccine booster in healthcare workers in Brazil.
Marra AR; Miraglia JL; Malheiro DT; Guozhang Y; Teich VD; Victor EDS; Pinho JRR; Cypriano A; Vieira LW; Polonio M; Ornelas RH; de Oliveira SM; Borges FA; Oler SCC; Ricardo VCV; Maezato AM; Callado GY; Schettino GPP; de Oliveira KG; Santana RAF; Malta FM; Amgarten D; Boechat AL; Kobayashi T; Salinas JL; Edmond MB; Rizzo LV
Antimicrob Steward Healthc Epidemiol; 2023; 3(1):e104. PubMed ID: 37396193
[TBL] [Abstract][Full Text] [Related]
4. An Observational Cohort Study on the Incidence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and B.1.1.7 Variant Infection in Healthcare Workers by Antibody and Vaccination Status.
Lumley SF; Rodger G; Constantinides B; Sanderson N; Chau KK; Street TL; O'Donnell D; Howarth A; Hatch SB; Marsden BD; Cox S; James T; Warren F; Peck LJ; Ritter TG; de Toledo Z; Warren L; Axten D; Cornall RJ; Jones EY; Stuart DI; Screaton G; Ebner D; Hoosdally S; Chand M; Crook DW; O'Donnell AM; Conlon CP; Pouwels KB; Walker AS; Peto TEA; Hopkins S; Walker TM; Stoesser NE; Matthews PC; Jeffery K; Eyre DW;
Clin Infect Dis; 2022 Apr; 74(7):1208-1219. PubMed ID: 34216472
[TBL] [Abstract][Full Text] [Related]
5. Factors Associated with Vaccine Breakthrough Incidence among Health Care Workers Vaccinated with Inactivated SARS-CoV2 Vaccine (CoronaVac).
Anshory M; Wahono CS; Pratama MZ; Rahman PA; Nugraha AS; Sekarani A
J Res Health Sci; 2022 Jun; 22(2):e00551. PubMed ID: 36511263
[TBL] [Abstract][Full Text] [Related]
6. [The Second Shot of CoronaVac Vaccine May Cause Reduction of Antibody Levels in People who Previously had COVID-19].
Topkaya AE; Keskin AÜ; Dalan AB; Çıragil P
Mikrobiyol Bul; 2022 Jan; 56(1):139-142. PubMed ID: 35088968
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of CoronaVac among healthcare workers in the setting of high SARS-CoV-2 Gamma variant transmission in Manaus, Brazil: A test-negative case-control study.
Hitchings MDT; Ranzani OT; Torres MSS; de Oliveira SB; Almiron M; Said R; Borg R; Schulz WL; de Oliveira RD; da Silva PV; de Castro DB; Sampaio VS; de Albuquerque BC; Ramos TCA; Fraxe SHH; da Costa CF; Naveca FG; Siqueira AM; de Araújo WN; Andrews JR; Cummings DAT; Ko AI; Croda J
Lancet Reg Health Am; 2021 Sep; 1():100025. PubMed ID: 34386791
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of BNT162b2 mRNA Coronavirus Disease 2019 (COVID-19) Vaccine Against Acquisition of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Among Healthcare Workers in Long-Term Care Facilities: A Prospective Cohort Study.
Muhsen K; Maimon N; Mizrahi A; Bodenheimer O; Cohen D; Maimon M; Grotto I; Dagan R
Clin Infect Dis; 2022 Aug; 75(1):e755-e763. PubMed ID: 34698808
[TBL] [Abstract][Full Text] [Related]
9. Short-term immune response after inactivated SARS-CoV-2 (CoronaVac®, Sinovac) and ChAdOx1 nCoV-19 (Vaxzevria®, Oxford-AstraZeneca) vaccinations in health care workers.
Jantarabenjakul W; Chantasrisawad N; Puthanakit T; Wacharapluesadee S; Hirankarn N; Ruenjaiman V; Paitoonpong L; Suwanpimolkul G; Torvorapanit P; Pradit R; Sophonphan J; Putcharoen O
Asian Pac J Allergy Immunol; 2022 Sep; 40(3):269-277. PubMed ID: 34717527
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of homologous and heterologous booster doses for an inactivated SARS-CoV-2 vaccine: a large-scale prospective cohort study.
Jara A; Undurraga EA; Zubizarreta JR; González C; Pizarro A; Acevedo J; Leo K; Paredes F; Bralic T; Vergara V; Mosso M; Leon F; Parot I; Leighton P; Suárez P; Rios JC; García-Escorza H; Araos R
Lancet Glob Health; 2022 Jun; 10(6):e798-e806. PubMed ID: 35472300
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of CoronaVac vaccination against COVID-19 development in healthcare workers: real-life data.
Copur B; Surme S; Sayili U; Tuncer G; Pehlivanoglu F; Sengoz G
Future Microbiol; 2022 Nov; 17():1381-1391. PubMed ID: 36169346
[TBL] [Abstract][Full Text] [Related]
12. Risks of catching COVID-19 according to vaccination status of healthcare workers during the SARS-CoV-2 Delta variant dominant period and their clinical characteristics.
Özüdoğru O; Acer Ö; Genç Bahçe Y
J Med Virol; 2022 Aug; 94(8):3706-3713. PubMed ID: 35419851
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy of Homologous and Heterologous Vaccine Applications on SARS-CoV-2 Omicron Variant: Cohort of Manisa Celal Bayar University Healthcare Workers].
Çiçek K; Özkaya Y; Eser E; Buran ZC; Öztürk Arıkan ZÖ; Akçalı S; Erbay Dündar P; Cengiz Özyurt B; Şenol Akar Ş; Özer D; Karadağ Yalçın F
Mikrobiyol Bul; 2023 Apr; 57(2):238-251. PubMed ID: 37067208
[TBL] [Abstract][Full Text] [Related]
14. Comparison of immunogenicity and reactogenicity of inactivated SARS-CoV-2 vaccine (CoronaVac) in previously SARS-CoV-2 infected and uninfected health care workers.
Soysal A; Gönüllü E; Karabayır N; Alan S; Atıcı S; Yıldız İ; Engin H; Çivilibal M; Karaböcüoğlu M
Hum Vaccin Immunother; 2021 Nov; 17(11):3876-3880. PubMed ID: 34324409
[TBL] [Abstract][Full Text] [Related]
15. Primary SARS-CoV-2 Infections, Re-infections and Vaccine Effectiveness during the Omicron Transmission Period in Healthcare Workers of Trieste and Gorizia (Northeast Italy), 1 December 2021-31 May 2022.
Cegolon L; Negro C; Mastrangelo G; Filon FL;
Viruses; 2022 Nov; 14(12):. PubMed ID: 36560692
[No Abstract] [Full Text] [Related]
16. Effectiveness of mRNA-BNT162b2, mRNA-1273, and ChAdOx1 nCoV-19 vaccines against COVID-19 in healthcare workers: an observational study using surveillance data.
Paris C; Perrin S; Hamonic S; Bourget B; Roué C; Brassard O; Tadié E; Gicquel V; Bénézit F; Thibault V; Garlantézec R; Tattevin P
Clin Microbiol Infect; 2021 Nov; 27(11):1699.e5-1699.e8. PubMed ID: 34265462
[TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 Reinfection Rate and Estimated Effectiveness of the Inactivated Whole Virion Vaccine BBV152 Against Reinfection Among Health Care Workers in New Delhi, India.
Malhotra S; Mani K; Lodha R; Bakhshi S; Mathur VP; Gupta P; Kedia S; Sankar J; Kumar P; Kumar A; Ahuja V; Sinha S; Guleria R; ; Dua A; Ahmad S; Sathiyamoorthy R; Sharma A; Sakya T; Gaur V; Chaudhary S; Sharma S; Madan D; Gupta A; Virmani S; Gupta A; Yadav N; Sachdeva S; Sharma S; Singh S; Pandey A; Singh M; Jhurani D; Sarkar S; Lokade AK; Mohammad A; Pandit S; Dubey R; Singh AK; Gohar N; Soni D; Bhattacharyya A; Rai S; Tummala S; Gupta I; Shukla S
JAMA Netw Open; 2022 Jan; 5(1):e2142210. PubMed ID: 34994793
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of CoronaVac in preventing COVID-19 in healthcare workers.
Bayhan GI; Guner R
Hum Vaccin Immunother; 2022 Dec; 18(1):2020017. PubMed ID: 35172694
[TBL] [Abstract][Full Text] [Related]
19. [Investigation of Humoral and Cellular Immunity in TOBB ETÜ Hospital Workers After Three Doses of CoronaVac Vaccination and after One Dose of Comirnaty Vaccination Following Two Doses of CoronaVac].
Özyurda F; Ardıçoğlu Akışın Y; Mert T; Poyraz B; Özkan Y; Turan M; Göçmen JS; Yücel A; Akar N
Mikrobiyol Bul; 2022 Jul; 56(3):387-403. PubMed ID: 35960233
[TBL] [Abstract][Full Text] [Related]
20. Reduction in COVID-19 prevalence in healthcare workers in a university hospital in southern Brazil after the start of vaccination.
Toniasso SCC; Fernandes FS; Joveleviths D; Filho FFD; Takahasi AY; Baldin CP; Pereira RM; da Silva LP; Brum MCB
Int J Infect Dis; 2021 Aug; 109():283-285. PubMed ID: 34271203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
